Common use of REPORT, IRO REPORTS AND ANNUAL REPORTS Clause in Contracts

REPORT, IRO REPORTS AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 90 days after the Effective Date, Xx. Xxxxx shall submit a written report to OIG summarizing the status of its implementation of the requirements of this IA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. a copy of the notice required by Section III.A, a description of where the notice is posted, and the date the notice was posted;‌ 2. the following information regarding the IRO: (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this IA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Xx. Xxxxx and the Cancer Centers;‌ 3. a copy of the search result print screens demonstrating that Xx. Xxxxx has screened all Covered Persons against the Exclusion List, as required by Section III.E, within 30 days of the Effective Date;‌ 4. a copy of any certifications from Xx. Xxxxx and the third party billing company required by Section III.I (if applicable);‌ 5. a list of all of Xx. Xxxxx’x and the Cancer Centers’ locations (including locations and mailing addresses), the corresponding name under which each location is doing business, and each location’s Medicare and state Medicaid program provider number(s), and/or supplier number(s); and‌ 6. a certification by Xx. Xxxxx that: (a) he has reviewed the IA in its entirety, understands the requirements described within, and maintains a copy for reference; (b) to the best of his knowledge, except as otherwise described in the Implementation Report, Xx. Xxxxx and the Cancer Centers are in compliance with all of‌ the requirements of this IA; (c) he has reviewed the Implementation Report and has made a reasonable inquiry regarding its content and believes that the information is accurate and truthful; and (d) he understands that the certification is being provided to and relied upon by the United States

REPORT, IRO REPORTS AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 90 days after the Effective Date, Xx. Xxxxx Pharmacy shall submit a written report to OIG summarizing the status of its implementation of the requirements of this IA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;‌ 2. a list of the Policies and Procedures required by Section III.B.;‌‌ 3. a copy of the notice required by Section III.AIII.C, a description of where the notice is posted, and the date the notice was posted;‌ 24. the following information regarding the IRO: (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this IA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Xx. Xxxxx and the Cancer Centers;‌Pharmacy;‌ 35. a copy of the search result print screens demonstrating that Xx. Xxxxx Pharmacy has screened all Covered Persons against the Exclusion List, List as required by Section III.E, III.F within 30 days of the Effective Date;‌ 46. a copy of Xxxxx Pharmacy’s policies and procedures regarding the identification, quantification and repayment of Overpayments required by Section III.H;‌ 7. a copy of any certifications from Xx. Xxxxx Pharmacy and the third party billing company required by Section III.I III.J (if applicable);‌ 58. a list of all of Xx. Xxxxx’x and the Cancer Centers’ Xxxxx Pharmacy’s locations (including locations and mailing addresses), the corresponding name under which each location is doing business, and each location’s Medicare and state Medicaid program provider number(s), and/or supplier number(s); and‌ 69. a certification by Xx. Xxxxx the Compliance Officer that: (a) he the Compliance Officer has reviewed the IA in its entirety, understands the requirements described within, and maintains a copy for reference; (b) to the best of his or her knowledge, except as otherwise described in the Implementation Report, Xx. Xxxxx and the Cancer Centers are Pharmacy is in compliance with all of‌ of the requirements of this IA; (c) he or she has reviewed the Implementation Report and has made a reasonable inquiry regarding its content and believes that the information is accurate and truthful; and (d) he or she understands that the this certification is being provided to and relied upon by the United StatesStates.‌

REPORT, IRO REPORTS AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 90 150 days after the Effective Date, Xx. Xxxxx HOK shall submit a written report to OIG summarizing the status of its implementation of the requirements of this IA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;‌ 2. a list of the Policies and Procedures required by Section III.B.; 3. a copy of the notice required by Section III.AIII.C, a description of where the notice is posted, and the date the notice was posted;‌ 24. the following information regarding the IRO: (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this IA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Xx. Xxxxx and the Cancer Centers;‌HOK;‌ 35. a copy of the search result print screens demonstrating that Xx. Xxxxx HOK has screened all Covered Persons against the Exclusion List, List as required by Section III.E, III.F within 30 days of the Effective Date;‌ 46. a copy of any certifications from Xx. Xxxxx HOK’s policies and procedures regarding the third party billing company identification, quantification and repayment of Overpayments required by Section III.I (if applicable);‌III.H;‌ 57. a list of all of Xx. Xxxxx’x and the Cancer Centers’ HOK’s locations (including locations and mailing addresses), the corresponding name under which each location is doing business, and each location’s Medicare and state Medicaid program provider number(s), and/or supplier number(s); and‌ 68. a certification by Xx. Xxxxx the Compliance Officer that: (a) he the Compliance Officer has reviewed the IA in its entirety, understands the requirements described within, and maintains a copy for reference; (b) to the best of his or her knowledge, except as otherwise described in the Implementation Report, Xx. Xxxxx and the Cancer Centers are HOK is in compliance with all of‌ of the requirements of this IA; (c) he or she has reviewed the Implementation Report and has made a reasonable inquiry regarding its content and believes that the information is accurate and truthful; and (d) he or she understands that the this certification is being provided to and relied upon by the United StatesStates.‌

REPORT, IRO REPORTS AND ANNUAL REPORTS. ‌‌‌ A. Implementation Report‌ Within 90 days after the Effective Date, Xx. Xxxxx Xxxxxxxxxx-AFAS shall submit a written report to OIG summarizing the status of its implementation of the requirements of this IA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. a copy of the notice required by Section III.A, a description of where the notice is posted, and the date the notice was posted;‌ 2. the following information regarding the IRO: (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this IA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Xx. Xxxxx and the Cancer Centers;‌Xxxxxxxxxx-AFAS;‌ 3. a copy of the search result print screens demonstrating that Xx. Xxxxx Xxxxxxxxxx-AFAS has screened all Covered Persons against the Exclusion List, as required by Section III.Esection III.D, within 30 days of the Effective Date;‌ 4. a copy of any certifications from Xx. Xxxxx Xxxxxxxxxx-AFAS and the third party billing company required by Section III.I (if applicable);‌III.H;‌ 5. a list of all of Xx. Xxxxx’x and the Cancer Centers’ Xxxxxxxxxx-AFAS’s locations (including locations and mailing addresses), the corresponding name under which each location is doing business, and each location’s Medicare and state Medicaid program provider number(s), and/or supplier number(s); and‌ 6. a certification by Xx. Xxxxx Xxxxxxxxxx-AFAS that: (a) he or she has reviewed the IA in its entirety, understands the requirements described within, and maintains a copy for reference; (b) to the best of his or her knowledge, except as otherwise described in the Implementation Report, Xx. Xxxxx and the Cancer Centers are Xxxxxxxxxx-AFAS is in compliance with all of‌ of the requirements of this IA; and (c) he or she has reviewed the Implementation Report and has made a reasonable inquiry regarding its content and believes that the information is accurate and truthful; and (d) he understands that the certification is being provided to and relied upon by the United Statestruthful.‌

REPORT, IRO REPORTS AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 90 days after the Effective Date, Xx. Xxxxx CBHA shall submit a written report to OIG summarizing the status of its implementation of the requirements of this IA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;‌‌‌ 2. a list of the Policies and Procedures required by Section III.B.; 3. a copy of the notice required by Section III.AIII.C, a description of where the notice is posted, and the date the notice was posted;‌ 24. the following information regarding the IRO: (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this IA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Xx. Xxxxx and the Cancer Centers;‌CBHA;‌ 35. a copy of the search result print screens demonstrating that Xx. Xxxxx CBHA has screened all Covered Persons against the Exclusion List, List as required by Section III.E, III.F within 30 days of the Effective Date;‌ 46. a copy of any certifications from Xx. Xxxxx CBHA’s policies and procedures regarding the third party billing company identification, quantification and repayment of Overpayments required by Section III.I (if applicable);‌III.H;‌ 57. a list of all of Xx. Xxxxx’x and the Cancer Centers’ CBHA’s locations (including locations and mailing addresses), the corresponding name under which each location is doing business, and each location’s Medicare and state Medicaid program provider number(s), and/or supplier number(s); and‌ 68. a certification by the Compliance Officer that: (a) the Compliance Officer has reviewed the IA in its entirety, understands the requirements described within, and maintains a copy for reference; (b) to the best of his or her knowledge, except as otherwise described in the Implementation Report, CBHA is in compliance with all of the requirements of this IA; (c) he or she has reviewed the Implementation Report and has made a reasonable inquiry regarding its content and believes that the information is accurate and truthful; and (d) he or she understands that this certification is being provided to and relied upon by the United States.‌ 9. a certification by Xx. Xxxxx Xxxxxx Awwa that: (a) he has reviewed the IA in its entirety, understands the requirements described within, and maintains a copy for reference; (b) to the best of his knowledge, except as otherwise described in the Implementation Report, Xx. Xxxxx and the Cancer Centers are CBHA is in compliance with all of‌ of the requirements of this IA; (c) he has reviewed the Implementation Report and has made a reasonable inquiry regarding its content and believes that the information is accurate and truthful; and (d) he understands that the certification is being provided to and relied upon by the United StatesIA;‌

REPORT, IRO REPORTS AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 90 days after the Effective Date, Xx. Xxxxx Xxxxxxxx Clinic shall submit a written report to OIG summarizing the status of its implementation of the requirements of this IA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. a copy of the notice required by Section III.A, a description of where the notice is posted, and the date the notice was posted;‌ 2. the following information regarding the IRO: (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this IA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Xx. Xxxxx Xxxxxxxx Clinic that includes a summary of all current and prior engagements between Xxxxxxxx Clinic and the Cancer Centers;‌IRO;‌ 3. a copy of the search result print screens demonstrating that Xx. Xxxxx Xxxxxxxx Clinic has screened all Covered Persons against the Exclusion List, as required by Section III.EIII.D, within 30 days of the Effective Date;‌ 4. a copy of any certifications from Xx. Xxxxx Xxxxxxxx Clinic and the third third-party billing company required by Section III.I III.H (if applicable);‌ 5. a list of all of Xx. Xxxxx’x and the Cancer Centers’ Xxxxxxxx Clinic’s locations (including locations and mailing addresses), the corresponding name under which each location is doing business, and each location’s Medicare and state Medicaid program provider number(s), and/or supplier number(s); and‌ 6. a certification by Xx. Xxxxx Xxxx X. Escandon, Jr. that: (a) he has reviewed the IA in its entirety, understands the requirements described within, and maintains a copy for reference; (b) to the best of his knowledge, except as otherwise described in the Implementation Report, Xx. Xxxxx and the Cancer Centers are Xxxxxxxx Clinic is in compliance with all of‌ of the requirements of this IA; (c) he has reviewed the Implementation Report and has made a reasonable inquiry regarding its content and believes that the information is accurate and truthful; and (d) he understands that the certification is being provided to and relied upon by the United StatesStates‌

REPORT, IRO REPORTS AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 90 days after the Effective Date, Xx. Xxxxx Princeton Pathology shall submit a written report to OIG summarizing the status of its implementation of the requirements of this IA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, address, phone number, and position description of the Compliance Contact required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Contact may have;‌ 2. a list of the Policies and Procedures required by Section III.B.; 3. a copy of the notice required by Section III.AIII.C, a description of where the notice is posted, and the date the notice was posted;‌ 24. the following information regarding the IRO: (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate demonstrate‌ that the IRO has the qualifications outlined in Appendix A to this IA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Xx. Xxxxx Princeton Pathology that includes a summary of all current and prior engagements between Princeton Pathology and the Cancer Centers;‌IRO; 35. a copy of the search result print screens demonstrating that Xx. Xxxxx Princeton Pathology has screened all Covered Persons against the Exclusion List, List as required by Section III.E, III.F within 30 days of the Effective Date;‌ 46. a copy of Princeton Pathology’s policies and procedures regarding the identification, quantification and repayment of Overpayments required by Section III.H;‌ 7. a copy of any certifications from Xx. Xxxxx Princeton Pathology and the third party billing company required by Section III.I III.J (if applicable);‌ 58. a list of all of Xx. Xxxxx’x and the Cancer Centers’ Princeton Pathology’s locations (including locations and mailing addresses), the corresponding name under which each location is doing business, and each location’s Medicare and state Medicaid program provider number(s), and/or supplier number(s); and‌ 69. a certification by Xx. Xxxxx the Compliance Contact and the Chief Executive Officer that: (a) he or she has reviewed the IA in its entirety, understands the requirements described within, and maintains a copy for reference; (b) to the best of his or her knowledge, except as otherwise described in the Implementation Report, Xx. Xxxxx and the Cancer Centers are Princeton Pathology is in compliance with all of‌ of the requirements of this IA; (c) he or she has reviewed the Implementation Report and has made a reasonable inquiry regarding its content and believes that the information is accurate and truthful; and (d) he or she understands that the this certification is being provided to and relied upon by the United StatesStates.‌

REPORT, IRO REPORTS AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 90 days after the Effective Date, Xx. Xxxxx Northwest ENT shall submit a written report to OIG summarizing the status of its implementation of the requirements of this IA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have; ·‌ 2. a list of the Policies and Procedures required by Section III.B.; 3. a copy of the notice required by Section III.AIII.C, a description of where the notice is posted, and the date the notice was posted;‌ 24. the following information regarding the IRO: (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this IA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Xx. Xxxxx and the Cancer Centers;‌Northwest ENT;‌ 35. a copy of the search result print screens demonstrating that Xx. Xxxxx Northwest ENT has screened all Covered Persons against the Exclusion List, List as required by Section III.E, III.F within 30 days of the Effective Date;‌Date;‌‌ 46. a copy of Northwest ENT's policies and procedures regarding the identification, quantification and repayment of Overpayments required by Section III.H;‌ 7. a copy of any certifications from Xx. Xxxxx Northwest ENT and the third party billing company required by Section III.I III.J (if applicable);‌ 58. a list of all of Xx. Xxxxx’x and the Cancer Centers’ Northwest ENT's locations (including locations and mailing addresses), the corresponding name under which each e�ch location is doing business, and each location’s 's Medicare and state Medicaid program provider number(s), and/or supplier number(s); and‌ 6. a certification by Xx. Xxxxx that: (a) he has reviewed the IA in its entirety, understands the requirements described within, and maintains a copy for reference; (b) to the best of his knowledge, except as otherwise described in the Implementation Report, Xx. Xxxxx and the Cancer Centers are in compliance with all of‌ the requirements of this IA; (c) he has reviewed the Implementation Report and has made a reasonable inquiry regarding its content and believes that the information is accurate and truthful; and (d) he understands that the certification is being provided to and relied upon by the United States

REPORT, IRO REPORTS AND ANNUAL REPORTS. ‌ A. Implementation Report‌ Within 90 days after the Effective Date, Xx. Xxxxx EPIPG shall submit a written report to OIG summarizing the status of its implementation of the requirements of this IA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A, and a summary of other noncompliance job responsibilities the Compliance Officer may have;‌ 2. a list of the Policies and Procedures required by Section III.B.; 3. a copy of the notice required by Section III.AIII.C, a description of where the notice is posted, and the date the notice was posted;‌ 24. the following information regarding the IRO: (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this IA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to Xx. Xxxxx EPIPG that includes a summary of all current and prior engagements between EPIPG and the Cancer Centers;‌IRO;‌ 35. a copy of the search result print screens demonstrating that Xx. Xxxxx EPIPG has screened all Covered Persons against the Exclusion List, List as required by Section III.E, III.F within 30 days of the Effective Date;‌ 46. a copy of EPIPG’s policies and procedures regarding the identification, quantification and repayment of Overpayments required by Section III.H;‌‌‌ 7. a copy of any certifications from Xx. Xxxxx EPIPG and the third party billing company required by Section III.I III.J (if applicable);‌ 58. a list of all of Xx. Xxxxx’x and the Cancer Centers’ EPIPG’s locations (including locations and mailing addresses), the corresponding name under which each location is doing business, and each location’s Medicare and state Medicaid program provider number(s), and/or supplier number(s); and‌ 6. a certification by Xx. Xxxxx that: (a) he has reviewed the IA in its entirety, understands the requirements described within, and maintains a copy for reference; (b) to the best of his knowledge, except as otherwise described in the Implementation Report, Xx. Xxxxx and the Cancer Centers are in compliance with all of‌ the requirements of this IA; (c) he has reviewed the Implementation Report and has made a reasonable inquiry regarding its content and believes that the information is accurate and truthful; and (d) he understands that the certification is being provided to and relied upon by the United States